TSW
LIVN icon

Thompson Siegel & Walmsley’s LivaNova LIVN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,000
Closed -$1.12M – 765
2018
Q3 		$1.12M Buy
9,000
+5,000
+125% +$590K 0.01% 294
2018
Q2 		$399K Buy
+4,000
New +$363K 0.01% 362

Other funds holding LIVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Thompson Siegel & Walmsley's LIVN Position: Q4 2018 in Review

Thompson Siegel & Walmsley sold out of LivaNova (LIVN) in Q4 2018, closing a stake of 9,000 shares — an estimated $1.12M sold.

Thompson Siegel & Walmsley first reported a position in LIVN in Q2 2018 and held it in 2 quarters. The position peaked at $1.12M in Q3 2018. 251 funds tracked by Wall St. Rank hold LIVN as of Q4 2018.

  • Thompson Siegel & Walmsley reported no remaining LivaNova position as of Q4 2018 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 9,000 LivaNova shares in Q4 2018, an estimated $1.12M.
  • Thompson Siegel & Walmsley first reported a position in LivaNova in Q2 2018 and held it in 2 quarters.
  • Thompson Siegel & Walmsley's LivaNova position peaked at $1.12M in Q3 2018.
  • 251 funds tracked by Wall St. Rank held LivaNova as of Q4 2018.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2018, filed 11 Feb 2019.